Description
Despite APOE ε4 and CSF AD biomarkers being established risk factors, they showed no interaction with sleep-cognition relationships in this cognitively normal cohort. This contradicts expectations that early AD pathology would alter sleep’s impact on cognitive function, suggesting current understanding of preclinical AD mechanisms is incomplete.
Gap type: contradiction Source paper: Remote assessments of sleep and cognition in cognitively normal older adults at risk for Alzheimer disease. (2026, Sleep medicine, PMID:41456359)
Evidence summary
{“resolution_pipeline”: “scidex.atlas.gap_closure_pipeline”, “task_id”: “f4f7b129-0f43-4c84-abd8-20d4e701842d”, “evaluated_at”: “2026-04-28T19:10:46.486822+00:00”, “resolution_summary”: “Resolved by hypothesis h-SDA-2026-04-26-gap-debate-20260417-033134-20519caa-01-residual-vascular-amyloid-prevents-complete-csf–ed8812948d: Residual Vascular Amyloid Prevents Complete CSF p-tau217 Normalization, Requiring Composite Cessation Criteria. Supporting evidence includes debate sess_SDA-2026-04-14-gap-pubmed-20260411-072446-a32fa49c.”, “match_counts”: {“hypothesis_matches”: 5, “debate_matches”: 5, “paper_matches”: 0}, “hypothesis_matches”: [{“id”: “h-SDA-2026-04-26-gap-debate-20260417-033134-20519caa-01-residual-vascular-amyloid-prevents-complete-csf–ed8812948d”, “title”: “Residual Vascular Amyloid Prevents Complete CSF p-tau217 Normalization, Requiring Composite Cessation Criteria”, “score”: 0.347, “reason”: “5 token overlaps; entity overlap: apoe, csf”, “analysis_id”: “SDA-2026-04-26-gap-debate-20260417-033134-20519caa”, “target_gene”: “APOE, CLU”, “target_pathway”: null, “disease”: null, “composite_score”: 0.5850000000000001, “confidence_score”: 0.363, “status”: “proposed”, “pubmed_evidence_ids”: [“32084328”, “36539417”, “37106692”, “none cited but standard clinical imaging”]}, {“id”: “h-aa1f5de5cd”, “title”: “TREM2 haploinsufficiency dysregulates microglial synaptic surveillance, switching from protective ‘disease-associated microglia’ to neurotoxic ‘inflammasome-active’ states”, “score”: 0.226, “reason”: “18 token overlaps; entity overlap: apoe”, “analysis_id”: “SDA-2026-04-02-gap-synaptic-pruning-microglia”, “target_gene”: “TREM2, TYROBP (DAP12), APOE”, “target_pathway”: null, “disease”: “neurodegeneration”, “composite_score”: 0.7, “confidence_score”: 0.22, “status”: “proposed”, “pubmed_evidence_ids”: [“26598730”, “27753624”, “28602351”, “28802038”, “29070674”]}, {“id”: “h-c410043ac4”, “title”: “Antisense Oligonucleotide-Mediated APOE4 Haploinsufficiency”, “score”: 0.224, “reason”: “17 token overlaps; entity overlap: apoe”, “analysis_id”: “SDA-2026-04-02-gap-apoe4-targeting”, “target_gene”: “APOE”, “target_pathway”: null, “disease”: “neurodegeneration”, “composite_score”: 0.72, “confidence_score”: 0.75, “status”: “proposed”, “pubmed_evidence_ids”: [“25999527”, “33230312”, “clinical-aso-studies”, “germline-knockout-studies”]}, {“id”: “h-15336069”, “title”: “APOE Isoform Conversion Therapy”, “score”: 0.223, “reason”: “21 token overlaps; entity overlap: apoe”, “analysis_id”: “sda-2026-04-01-gap-auto-fd6b1635d9”, “target_gene”: “APOE”, “target_pathway”: “CRISPR base editing / APOE allele conversion”, “disease”: “neurodegeneration”, “composite_score”: 0.717666, “confidence_score”: 0.45, “status”: “proposed”, “pubmed_evidence_ids”: [“23571587”, “29566236”, “33649586”, “34261473”, “34731344”]}, {“id”: “h-5d943bfc”, “title”: “Proteostasis Enhancement via APOE Chaperone Targeting”, “score”: 0.222, “reason”: “21 token overlaps; entity overlap: apoe”, “analysis_id”: “sda-2026-04-01-gap-auto-fd6b1635d9”, “target_gene”: “HSPA1A”, “target_pathway”: “HSP70/HSP40 chaperone-mediated proteostasis”, “disease”: “neurodegeneration”, “composite_score”: 0.7240110000000001, “confidence_score”: 0.65, “status”: “proposed”, “pubmed_evidence_ids”: [“15537890”, “16157603”, “28916615”, “29566236”, “32554827”]}], “debate_matches”: [{“id”: “sess_SDA-2026-04-14-gap-pubmed-20260411-072446-a32fa49c”, “title”: “The abstract shows TYROBP deficiency is neuroprotective despite being required for TREM2, CD33, and CR3 function - receptors associated with AD risk. This counterintuitive finding challenges current understanding of how these immune receptors contribute to AD pathogenesis.\n\nGap type: contradiction\nSource paper: Deficiency of TYROBP, an adapter protein for TREM2 and CR3 receptors, is neuroprotective in a mouse model of early Alzheimer’s pathology. (None, None, PMID:28612290)”, “score”: 0.47, “reason”: “13 token overlaps; entity overlap: pmid”, “analysis_id”: “SDA-2026-04-14-gap-pubmed-20260411-072446-a32fa49c”, “quality_score”: 0.56, “status”: “completed”, “target_artifact_id”: null, “target_artifact_type”: null}, {“id”: “sess_SDA-2026-04-14-gap-pubmed-20260410-184126-b2c3e2e8”, “title”: “This study shows APOE4 carriers have enhanced beneficial innate immune responses, directly contradicting the established view of APOE4 as purely detrimental in neurodegeneration. This paradox challenges fundamental assumptions about APOE4’s role in AD pathogenesis.\n\nGap type: contradiction\nSource paper: APOE genotype-specific differences in the innate immune response (2021, JAMA Neurology, PMID:33432245)”, “score”: 0.459, “reason”: “8 token overlaps; entity overlap: apoe, pmid”, “analysis_id”: “SDA-2026-04-14-gap-pubmed-20260410-184126-b2c3e2e8”, “quality_score”: 0.6, “status”: “completed”, “target_artifact_id”: null, “target_artifact_type”: null}, {“id”: “sess_SDA-2026-04-14-gap-pubmed-20260410-174607-708e8d91”, “title”: “The finding that Mertk/Axl deficiency increases viral susceptibility contradicts the established paradigm that TAM receptors dampen antiviral immunity. This unexpected protective role challenges current understanding of TAM receptor function in neuroinvasive infections.\n\nGap type: contradiction\nSource paper: The TAM receptor Mertk protects against neuroinvasive viral infection by maintaining blood-brain barrier integrity. (2015, Nature medicine, PMID:26523970)”, “score”: 0.421, “reason”: “12 token overlaps; entity overlap: pmid”, “analysis_id”: “SDA-2026-04-14-gap-pubmed-20260410-174607-708e8d91”, “quality_score”: 0.75, “status”: “completed”, “target_artifact_id”: null, “target_artifact_type”: null}, {“id”: “sess_SDA-2026-04-13-gap-pubmed-20260410-174607-708e8d91”, “title”: “The finding that Mertk/Axl deficiency increases viral susceptibility contradicts the established paradigm that TAM receptors dampen antiviral immunity. This unexpected protective role challenges current understanding of TAM receptor function in neuroinvasive infections.\n\nGap type: contradiction\nSource paper: The TAM receptor Mertk protects against neuroinvasive viral infection by maintaining blood-brain barrier integrity. (2015, Nature medicine, PMID:26523970)”, “score”: 0.421, “reason”: “12 token overlaps; entity overlap: pmid”, “analysis_id”: “SDA-2026-04-13-gap-pubmed-20260410-174607-708e8d91”, “quality_score”: 0.74, “status”: “completed”, “target_artifact_id”: null, “target_artifact_type”: null}, {“id”: “sess_SDA-2026-04-08-gap-pubmed-20260406-062202-5c32c50a_task_9aae8fc5”, “title”: “AD patients with TDP-43 pathology show worse cognitive impairment, but how TDP-43 mechanistically contributes to this severity is unknown. Understanding this could identify TDP-43 as a therapeutic target for cognitive preservation in AD.\n\nGap type: unexplained_observation\nSource paper: TDP-43 Pathology in Alzheimer’s Disease. (2021, Mol Neurodegener, PMID:34930382)”, “score”: 0.406, “reason”: “9 token overlaps; entity overlap: pmid”, “analysis_id”: “SDA-2026-04-08-gap-pubmed-20260406-062202-5c32c50a”, “quality_score”: 0.734, “status”: “completed”, “target_artifact_id”: null, “target_artifact_type”: null}], “paper_matches”: []}